• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经病理性疼痛的治疗考虑。

Treatment considerations in neuropathic pain.

机构信息

Department of Psychiatry, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, USA.

出版信息

Curr Treat Options Neurol. 2006 Sep;8(5):389-400. doi: 10.1007/s11940-006-0028-4.

DOI:10.1007/s11940-006-0028-4
PMID:16901378
Abstract

Neuropathy is a relatively common source of acute and chronic pain. Emerging evidence suggests several pathophysiological mechanisms underlying the neuropathic pain associated with various disorders. Antidepressants and anticonvulsants have largely been the mainstay of treatment. Pharmacologic treatment of neuropathy frequently requires use of multiple medications. Ideally, the selection of which medications to use should be based on targeting the multiple pathophysiologic mechanisms contributing to neuropathic pain transmission. Psychological variables may play a role in predisposing patients to chronic neuropathy after acute illness. In addition, comorbid conditions, especially depression, can complicate the presentation, clinical course, and response to treatment of patients with chronic pain. Treatment of depression may be essential to fully enlist the chronic neuropathic pain patient in comprehensive pain management and rehabilitative approaches.

摘要

神经病学是一种相对常见的急性和慢性疼痛源。新出现的证据表明,多种与疾病相关的神经病学疼痛存在几种病理生理学机制。抗抑郁药和抗惊厥药在很大程度上一直是治疗的主要方法。神经病学的药物治疗通常需要使用多种药物。理想情况下,选择使用哪种药物应该基于针对导致神经病学疼痛传递的多种病理生理学机制。心理变量可能在急性疾病后使患者易患慢性神经病学方面发挥作用。此外,合并症,特别是抑郁症,会使慢性疼痛患者的表现、临床病程和对治疗的反应复杂化。治疗抑郁症对于充分参与慢性神经病理性疼痛患者的全面疼痛管理和康复方法可能至关重要。

相似文献

1
Treatment considerations in neuropathic pain.神经病理性疼痛的治疗考虑。
Curr Treat Options Neurol. 2006 Sep;8(5):389-400. doi: 10.1007/s11940-006-0028-4.
2
Chronic pain and comorbid depression.慢性疼痛与共病性抑郁。
Curr Treat Options Neurol. 2005 Sep;7(5):403-12. doi: 10.1007/s11940-005-0032-0.
3
Neuropathic Pain.神经性疼痛
Continuum (Minneap Minn). 2017 Apr;23(2, Selected Topics in Outpatient Neurology):512-532. doi: 10.1212/CON.0000000000000462.
4
Diabetic neuropathic pain: Physiopathology and treatment.糖尿病性神经病理性疼痛:生理病理学与治疗
World J Diabetes. 2015 Apr 15;6(3):432-44. doi: 10.4239/wjd.v6.i3.432.
5
Pharmacotherapeutic Management of Neuropathic Pain in End-Stage Renal Disease.终末期肾病中神经性疼痛的药物治疗管理
Kidney Dis (Basel). 2020 May;6(3):157-167. doi: 10.1159/000504299. Epub 2020 Jan 20.
6
Painful Peripheral Neuropathy.疼痛性周围神经病变
Curr Treat Options Neurol. 2002 May;4(3):177-188. doi: 10.1007/s11940-002-0034-0.
7
Use of anticonvulsants for treatment of neuropathic pain.使用抗惊厥药治疗神经性疼痛。
Neurology. 2002 Sep 10;59(5 Suppl 2):S14-7. doi: 10.1212/wnl.59.5_suppl_2.s14.
8
Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy.用于神经性疼痛综合征的抗惊厥药:作用机制及治疗地位
Drugs. 2000 Nov;60(5):1029-52. doi: 10.2165/00003495-200060050-00005.
9
Treatment of painful peripheral neuropathy.疼痛性周围神经病的治疗
J Clin Neuromuscul Dis. 2002 Dec;4(2):50-9. doi: 10.1097/00131402-200212000-00002.
10
Anticonvulsants (antineuropathics) for neuropathic pain syndromes.用于神经性疼痛综合征的抗惊厥药(抗神经病药)。
Clin J Pain. 2000 Jun;16(2 Suppl):S67-72. doi: 10.1097/00002508-200006001-00012.

引用本文的文献

1
Tricyclic Antidepressant and/or γ-Aminobutyric Acid-Analog Use Is Associated With Fall Risk in Diabetic Peripheral Neuropathy.三环类抗抑郁药和/或γ-氨基丁酸类似物的使用与糖尿病周围神经病变患者的跌倒风险相关。
J Am Geriatr Soc. 2019 Jun;67(6):1174-1181. doi: 10.1111/jgs.15779. Epub 2019 Jan 29.
2
Role of vitamin D3 in treatment of lumbar disc herniation--pain and sensory aspects: study protocol for a randomized controlled trial.维生素D3在腰椎间盘突出症治疗中的作用——疼痛与感觉方面:一项随机对照试验的研究方案
Trials. 2014 Sep 25;15:373. doi: 10.1186/1745-6215-15-373.

本文引用的文献

1
Ion channel targets and treatment efficacy in neuropathic pain.离子通道靶点与神经性疼痛的治疗效果
J Pain. 2006 Jan;7(1 Suppl 1):S38-47. doi: 10.1016/j.jpain.2005.09.008.
2
Topiramate in chronic lumbar radicular pain.托吡酯治疗慢性腰神经根疼痛
J Pain. 2005 Dec;6(12):829-36. doi: 10.1016/j.jpain.2005.08.002.
3
Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster.带状疱疹后神经痛的心理社会风险因素:一项对带状疱疹患者的前瞻性研究
J Pain. 2005 Dec;6(12):782-90. doi: 10.1016/j.jpain.2005.07.006.
4
Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial.初治的带状疱疹后神经痛患者的治疗反应:双盲随机试验
J Pain. 2005 Nov;6(11):741-6. doi: 10.1016/j.jpain.2005.07.001.
5
Duloxetine vs. placebo in patients with painful diabetic neuropathy.度洛西汀与安慰剂治疗糖尿病性疼痛性神经病变患者的对比研究
Pain. 2005 Jul;116(1-2):109-18. doi: 10.1016/j.pain.2005.03.029.
6
Current trends in neuropathic pain treatments with special reference to fibromyalgia.神经性疼痛治疗的当前趋势,特别提及纤维肌痛
CNS Spectr. 2005 Apr;10(4):285-97. doi: 10.1017/s1092852900022616.
7
CLINICAL REVIEW: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy.临床综述:抗癫痫药物在慢性疼痛性糖尿病神经病变治疗中的应用
J Clin Endocrinol Metab. 2005 Aug;90(8):4936-45. doi: 10.1210/jc.2004-2376. Epub 2005 May 17.
8
The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.鞘内注射米那普明(一种5-羟色胺去甲肾上腺素再摄取抑制剂)在神经性疼痛大鼠模型中由单胺介导的抗痛觉过敏作用。
Anesth Analg. 2005 May;100(5):1406-1410. doi: 10.1213/01.ANE.0000149546.97299.A2.
9
Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity after surgery in rats.瑞波西汀和Xen2174对脊髓去甲肾上腺素转运体的抑制作用可减轻大鼠术后的触觉超敏反应。
Pain. 2005 Feb;113(3):271-276. doi: 10.1016/j.pain.2004.10.017.
10
Treatment of diabetic neuropathic pain with gabapentin alone or combined with vitamin B complex. preliminary results.单用加巴喷丁或联合复合维生素B治疗糖尿病性神经病理性疼痛:初步结果
Proc West Pharmacol Soc. 2004;47:109-12.